Experiences during critical periods of development through the mechanisms of programming have consequences on later health outcomes. Observations worldwide linking a small body size at birth with adult health outcomes have greatly added to our understanding of the early origins of several non-communicable diseases like coronary heart disease (CHD) and type 2 diabetes. The pattern of growth predisposing to CHD is characterized by a small body size at birth and thinness through infancy up to 2 years of age, followed by accelerated gain in weight and body mass index (BMI) later in childhood. The early growth patterns of individuals who later develop type 2 diabetes very much resemble the growth patterns of CHD, that is, a small body size at birth and thinness at 1 year of age followed by higher body mass indices later in childhood. Numerous studies support the importance of events during critical periods of growth in the pathogenesis of many non-communicable diseases like CHD and type 2 diabetes. There are several possible mechanisms through which a non-optimal early growth associated with accelerated weight gain in childhood could lead to these diseases. To get a better understanding of the patterns of growth affecting adult health outcomes, a life-course approach to the development of chronic diseases needs to be taken.
Introduction
Experiences during critical periods of development, for example, during fetal life and infancy, -through the mechanisms of programming have consequences on later health outcomes. According to the 'fetal origins hypothesis', an undernourished fetus makes persisting metabolic adaptations predisposing to, for example, coronary heart disease (CHD) and type 2 diabetes. 1 Observations worldwide linking a small body size at birth with adult health outcomes have greatly added to our understanding of the early origins of several non-communicable diseases like CHD and type 2 diabetes.
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Although a small body size at birth has repeatedly been associated with an increased risk of the above-mentioned diseases, there is still uncertainty about the effects of growth during childhood in modifying the risks established in utero. Furthermore, adult body size as well as lifestyle factors need to be considered when assessing the overall risk. 5, 8, 9 To get a better understanding of the patterns of growth affecting adult health outcomes, a life-course approach to the development of chronic diseases need to be taken care. Patterns of growth related to CHD and type 2 diabetes will be based on findings from the ongoing Helsinki Birth Cohort Study.
The Helsinki Birth Cohort Study
The Helsinki Birth Cohort Study is an ongoing study following up two birth cohorts consisting of 15 846 individuals born at the Helsinki University Central Hospital. 10 Data from the 'older cohort' (n ¼ 7086) born 1924-1933 includes birth characteristics as well as growth data between 7 and 15 years of age from school health-care records. The 'younger cohort' consists of 8760 individuals born 1934-1944 and has detailed data on childhood growth from birth up to 12 years of age. This cohort has on average 18 measurements of height and weight between birth and 12 years of age.
In these cohorts, information on early growth has been collected from birth, child welfare (only younger cohort) and school health-care records. These records include information on early and childhood growth, and also information on socio-economic factors and health-related factors during childhood.
The birth cohorts have been followed up from 1964 onwards by register linkage to national Finnish registers providing information on both morbidity and mortality.
A clinical examination of 2500 individuals from these cohorts has been undertaken providing more detailed information on metabolic and genetic aspects and their associations with early growth and adult health outcomes.
CHD and fetal growth
The original observation of the association between a low birthweight and later CHD came from the Hertfordshire study.
2 By now, this observation has been confirmed in a large number of studies in various populations around the world.
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In the Helsinki Birth Cohort Study, both a low birthweight and thinness at birth were associated with CHD risk later in life. 5 The hazard ratio for CHD among men born with a birthweight o2500 g was 3.63 compared with the group of men with a birthweight 44000 g. Similar associations were found in relation to ponderal index at birth -a marker of thinness (Table 1) . Fetal growth among those women who later developed CHD differed slightly from that of the men. 11 The pattern of fetal growth that most strongly predicted CHD was shortness at birth. The risk for developing CHD increased by B10% for each centimeter decrease in birth length.
CHD and growth during infancy
Not only fetal growth but also growth during infancy -the first year of life is associated with an increased risk for developing CHD. A small body size at 1 year of age adds to the CHD risk, independent of size at birth. 8 In fact, body size at 1 year of age is a strong independent predictor of later CHD. The hazard ratios for CHD according to weight at 1 year of age are given in Table 1 .
Our findings suggest that a relative gain in weight during infancy is associated with a reduced risk for CHD later in life. In other words, we have found no evidence to support the hypothesis that promotion of early growth in the first few months after birth will adversely affect the cardiovascular health.
Childhood growth and CHD
CHD is associated with overweight and obesity in adult life and a higher adult body mass index (BMI) modifies the risk associated with a small body size at birth. Therefore, a question of great interest is whether the increased CHD risk associated with a small body size at birth and during the first years of life is modified by later childhood growth.
Findings from the Helsinki Birth Cohort Studies show that CHD risk is associated with a small body size at birth followed by an above-average BMI during later childhood. The consequences of becoming relatively overweight in childhood are conditioned and modified by growth during fetal life and early childhood. 12 Hazard ratios for death from CHD according to birth size and BMI at age 2 and 11 years are shown in Table 2 . Figure 1 shows the childhood growth patterns of men who developed CHD from the Helsinki Birth Cohort Study. Their early and childhood growth is expressed as z-scores or s.d. scores. The z-score for the whole study cohort is set at zero. Therefore, an individual maintaining a steady position as either large or small in relation to other individuals follows a horizontal path on the graph. Those men who later developed CHD had a small body size at birth and they were thin through infancy up to 2 years of age. Thereafter, they showed accelerated gain in weight and BMI compared with the rest of the study cohort. Socio-economic factors, early growth and CHD Unfavorable socio-economic conditions are associated with increased rates of CHD. Early growth and socio-economic factors cannot be strictly separated from each other; Abbreviations: CHD, coronary heart disease; CI, confidence interval.
consequently, the risk for CHD associated with early growth is modified by socio-economic status. 13 In the Helsinki Birth Cohort Study, thinness at birth was related to an increased risk for CHD; however, this was most obvious among men from lower socio-economic conditions in childhood. Likewise, low adult socio-economic status and poor educational attainment were also associated with an increased risk for CHD, but only among those men with a small body size at birth
Type 2 diabetes and early growth
CHD is commonly associated with disturbances in glucose regulation and type 2 diabetes again is one major risk factor for CHD. Consequently, it is not surprising that CHD and type 2 diabetes share several early life-risk factors. The early growth patterns of individuals who later develop type 2 diabetes very much resemble the growth patterns of CHD, that is, a small body size at birth and thinness at 1 year of age followed by higher body mass indices later in childhood.
Although oobesity is the single most important risk factor for type 2 diabetes, most subjects in the Helsinki Birth Cohort Study who developed type 2 diabetes were non-obese during childhood by today's standards.
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BMI rebound and type 2 diabetes
The adiposity of children as measured by BMI reaches a minimum around 5-6 years of age before increasing again, that is, the BMI or adiposity rebound. 17 An early adiposity rebound has been associated with an increased risk of obesity later in childhood as well as in adult life. Owing to the close association between obesity and type 2 diabetes, one could speculate that an early adiposity rebound would be associated with an increased risk for type 2 diabetes in adult life. This was also the case and the prevalence of type 2 diabetes in relation to age at BMI rebound is shown in Figure 2 . The highest prevalence of type 2 diabetes was seen in those in whom the BMI rebound occurred before the age of 5 years. An early BMI rebound was preceded by thinness at birth and during infancy (Table 3 ). An early timing of the BMI rebound seems to be associated with the development of both obesity and type 2 diabetes.
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Different pathways of growth -same disease outcome
There are studies showing a U-shaped relationship between birthweight and type 2 diabetes, suggesting that both extremes of the birthweight spectrum are associated with an increased risk for type 2 diabetes. 4, 6 In the Helsinki Birth Cohort Study, the majority or two-thirds of the type 2 diabetics were born with a birthweight below 3500 g. After 7 years of age, they became larger than the rest of the cohort and the differences in weight and BMI increased. Among Early growth and coronary heart disease and type 2 diabetes JG Eriksson those with a birthweight 43500 g and who developed type 2 diabetes, slow growth in length during the first 3 months of life was associated with later disease. Rapid gain in BMI after 2 years of age increased the risk of type 2 diabetes in both birthweight groups, but this effect was greatest among children who had slow growth in length between birth and 3 months of age.
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Gene-environment interactions
It has been suggested that certain genotypes promoting survival during nutritional adversity could increase the risk of adult disease. The peroxisome proliferators activated receptor (PPAR) -g2 gene is a candidate gene for CHD and type 2 diabetes, being closely associated with both glucose and lipid metabolism. We have reported strong interactions between the PPAR-g2 gene and body size at birth with regard to insulin sensitivity, type 2 diabetes and lipid metabolism [19] [20] [21] ( Figure 3 ). This interaction between body size at birth and genotype reflects an interaction between the gene and the intrauterine environment. It is consistent with the hypothesis of developmental plasticity, where one genotype can give rise to different phenotypes dependent on the environment during development.
Underlying mechanisms
Numerous studies support the importance of events during critical periods of growth in the pathogenesis of many noncommunicable diseases like CHD and type 2 diabetes. There are several possible mechanisms through which a nonoptimal early growth associated with accelerated weight gain in childhood could lead to these diseases. Babies who are thin at birth have less muscle tissue. 22 If children born thin develop a relatively high BMI in childhood, they have a disproportionately high fat mass. 23, 24 In all adult BMI groups, those with small birth size had a lower muscle mass in later life. 22 This may predispose towards insulin resistance and metabolic syndrome, well-known risk factors for both CHD and type 2 diabetes. Both lean and fat compartments of body mass seem to be determined during fetal life. In both sexes, higher fat percentage is predicted by lower birthweight. Another potential underlying mechanism is associated with liver growth and liver development. People born small and who experience non-optimal growth during infancy might experience poor liver growth predisposing to hepatic insulin resistance and dyslipidemia -both wellknown risk factors for CHD and type 2 diabetes. Support for this comes from Hertfordshire were low weight at 1 year was associated with an atherogenic lipid profile in adult life. 25, 26 Similar associations between infant growth and adult lipid profiles have been observed in the Helsinki Birth Cohort Study.
The processes linking low weight gain in infancy with an early adiposity rebound are not known. It could reflect dietary factors and habits. On the other hand, an early adiposity rebound could be associated with programming of hormones and growth factors affecting fat metabolism, thereby predisposing to both obesity and type 2 diabetes.
The patterns of growth that predispose to adult diseases are complex. There is considerable evidence about the deleterious effects of childhood overweight and obesity. Therefore, treatment and prevention of childhood obesity should be high health priorities, especially in individuals with an increased disease risk due to early patterns of growth. 
